SHAPE Australia Corporation Limited (ASX:SHA)
Australia · Delayed Price · Currency is AUD 3.900
-0.020 (-0.51%)
Aug 4, 2025, 4:10 PM AEST
Intra-Cellular Therapies Market Cap
ASX:SHA has a market cap or net worth of 322.68 million as of August 4, 2025. Its market cap has increased by 63.04% in one year.
Market Cap
322.68M
Enterprise Value
227.94M
Revenue
902.63M
Ranking
n/a
PE Ratio
18.50
Stock Price
$3.90
Market Cap Chart
Since December 17, 2021, ASX:SHA's market cap has increased from 167.31M to 322.68M, an increase of 92.86%. That is a compound annual growth rate of 19.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 322.68M | 35.14% |
| Dec 31, 2024 | 238.78M | 60.68% |
| Dec 29, 2023 | 148.61M | 17.11% |
| Dec 29, 2022 | 126.90M | -32.24% |
| Dec 31, 2021 | 187.29M | 11.94% |
| Dec 17, 2021 | 167.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transurban Group | 42.83B |
| Brambles | 32.31B |
| SGH Limited | 20.65B |
| Qantas Airways | 16.15B |
| ALS Limited | 9.16B |
| Reece | 8.55B |
| Qube Holdings | 7.69B |
| Atlas Arteria | 7.54B |